-
Thematic Analysis
Top 20 Oil and Gas Themes in 2024 – Thematic Intelligence
Focusing deeper into the ‘Top 20 Oil and Gas Themes in 2024 Thematic Intelligence Report can help you answer the really important strategic questions for 2024: What are the critical business risks you face in 2024? Which are the most important oil and gas technologies to focus on in 2024? Who are the leading companies for these top oil and gas themes? Where are your competitors investing for tomorrow? How can you better understand your customers’ key challenges? What is...
-
Analyst Opinions
Net Zero by 2050 – Industrial Decarbonization Gains Momentum (Vol.2)
Net Zero by 2050 Overview Businesses and tech giants globally are focusing on low-carbon products, renewables, and EVs to achieve net zero emissions. Key sectors such as aerospace, automotive, and technology are advancing sustainability through innovations in hydrogen, EVs, fuel cells, and smart energy solutions among others. The “Net Zero by 2050” report outlines decarbonization-related deals value and volume trends, VC investment activity and geographic trends, and leading investors. The report also provides facts and figures related to climate change,...
-
Product Insights
Reproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Product Insights
NewHepatitis C – Drugs In Development, 2024
Empower your strategies with our Hepatitis C – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis C is a contagious viral infection affecting the liver. It spreads on contact with infected blood. It may be a mild condition or may be chronic, leading to various complications. The characteristic symptoms include abdominal pain, fatigue, fever, jaundice, loss of appetite, nausea, and vomiting. The predisposing factors of hepatitis C include dialysis, organ transplant, and blood transfusion. The offspring of...
-
Product Insights
NewHypertrophic Cardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Hypertrophic Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Hypertrophic cardiomyopathy (HCM) is a disease in which the heart muscle (myocardium) becomes abnormally thick (hypertrophied). The thickened heart muscles make it harder for the heart to pump blood. Symptoms include chest pain, especially during exercise; sensation of rapid, fluttering or pounding heartbeats; and heart murmur. Hypertrophic cardiomyopathy usually is inherited. Treatment includes beta blockers, calcium channel blockers, and blood thinners. The...
-
Product Insights
NewDiastolic Heart Failure – Drugs In Development, 2024
Empower your strategies with our Diastolic Heart Failure (HFpEF) – Drugs In Development, 2024 report and make more profitable business decisions. Diastolic heart failure, also known as heart failure with preserved ejection fraction, is a condition in which the heart's main pumping chamber becomes stiff and unable to fill properly. One of the two types of left-sided heart failure is diastolic heart failure. Main causes include high blood pressure, diabetes, coronary artery disease, and obesity. Untreated diastolic heart failure has the...
-
Product Insights
NewCardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Cardiomyopathy a disease of the heart muscle, where the walls of the heart chambers have become stretched, thickened or stiff. This affects the heart's ability to pump blood around the body. Most types of cardiomyopathy are inherited. It can also be caused by other conditions, or risk factors, but for some people the cause is unknown. Cardiomyopathy can affect people of all ages...
-
Product Insights
NewGouty Arthritis (Gout) – Drugs In Development, 2024
Empower your strategies with our Gouty Arthritis (Gout) – Drugs In Development, 2024 report and make more profitable business decisions. Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol...
-
Product Insights
NewMusculoskeletal Inflammation – Drugs In Development, 2024
Empower your strategies with our Musculoskeletal Inflammation – Drugs In Development, 2024 report and make more profitable business decisions. Musculoskeletal inflammation refers to the body's response to irritation, injury, or infection affecting muscles, bones, joints, ligaments, or tendons. Conditions like arthritis, tendinitis, bursitis, or muscle strains often trigger this response. Inflammation manifests as pain, swelling, stiffness, and reduced mobility in the affected area. Causes vary—from overuse or trauma to autoimmune disorders like rheumatoid arthritis. Treatment aims to reduce inflammation and manage...